| Combler les lacunes dans les tests de dépistage de l'hépatite | Bulletin des médecins suisses |  | | 2018 | 482 | 225 |
|
| Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030? | PLOS ONE | | | 2018 | 435 | 246 |
|
| Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030 | Swiss Medical Weekly | | | 2017 | 951 | 262 |
|
| Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland | PloS one | | | 2015 | 629 | 1,413 |
|
| Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland | Schweizerische medizinische Wochenschrift | | | 2015 | 622 | 269 |
|
| Cost-effectiveness analysis of sofosbuvir compared to current standard treatment in Swiss patients with chronic hepatitis C | PloS one | | | 2015 | 739 | 444 |
|
| Hepatitis B and C in Switzerland - healthcare provider initiated testing for chronic hepatitis B and C infection | Schweizerische medizinische Wochenschrift |  | | 2013 | 688 | 0 |
|
| Vaccine safety controversies and the future of vaccination programs | The Pediatric infectious disease journal | | | 2005 | 648 | 0 |
|
| FluNet as a tool for global monitoring of influenza on the Web | JAMA | | | 1998 | 719 | 0 |
|
